Manulife Financial

Manulife missed its last earnings estimate by 24.36%, and the stock still trades at 11.9 times trailing earnings.

If you own Manulife, you own a cheap insurer that needs cleaner earnings execution.

mfc

financials large cap updated dec 26, 2025
$35.76
market cap ~$60B · 52-week range $21–$36
xvary composite: 80 / 100 · above average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
Manulife sells insurance, retirement products, and investment management across Canada, the U.S., and Asia.
how it gets paid
Last year Manulife Financial made n/a in revenue. life insurance was the main engine at n/a, or 20% of sales.
what just happened
The last report missed estimates by 24.36%, even though full-year 2025 EPS still reached $3.00 from the quarterly figures provided.
At a glance
A balance sheet — strong enough to weather a downturn
95/100 earnings predictability — you can trust these numbers
11.9x trailing p/e — the market's not buying it — or you found a deal
3.7% dividend yield — cash in your pocket every quarter
12.5% return on capital — nothing to write home about
xvary composite: 80/100 — above average
What they do
Manulife sells insurance, retirement products, and investment management across Canada, the U.S., and Asia.
Manulife wins because leaving your insurer and retirement provider is a paperwork marathon, not a tap on your phone. That stickiness shows up in a 95 earnings predictability score and 90 out of 100 price stability, based on the company profile data above. It is also Canada’s largest life insurer, so scale helps it spread products through the same distribution network.
financials large-cap insurance asset-management dividend
How they make money
n/a annual revenue
life insurance
n/a
pension products
n/a
annuities
n/a
mutual funds
n/a
reinsurance and investment management
n/a
The products that matter
underwrites protection products
Life Insurance
A balance sheet · 14% roe
This is the core promise of the business: write long-duration policies, invest the float, and do it with enough discipline to produce a 14% return on equity.
core engine
manages client money
Investment Management Services
95 / 100 predictability
Fee income matters because it is usually steadier than underwriting results. The 95/100 earnings predictability score suggests this mix is doing some of the smoothing work.
stability layer
transfers blocks of risk
Reinsurance
C$5.4B transaction
The C$5.4B reinsurance deal is not just financial plumbing. It is management actively reshaping the balance sheet inside a $60B company.
capital lever
Key numbers
7%
debt to capital
Long-term debt means money owed later. At 7% of capital, borrowing is a small part of the stack, so you are not buying a balance-sheet dare.
11.9x
trailing p/e
Price-to-earnings means what investors pay for each dollar of profit. At 11.9 times, you are paying less than many large financial stocks for current earnings.
3.7%
dividend yield
Dividend yield means cash paid to you relative to the stock price. At 3.7%, you get paid while waiting for earnings to improve.
12.5%
return on capital
Return on capital means profit from money put into the business. At 12.5%, Manulife clears the bar for a mature insurer.
Financial health
A
strength
  • balance sheet grade A — very strong financial position
  • risk rank 2 — safer than 80% of stocks
  • price stability 90 / 100
  • long-term debt $4.6B (7% of capital)
  • return on equity 14% — $0.14 profit for every $1 investors have put in
A — among the top-rated companies for balance sheet quality.
Total return vs. market

You invested $10,000 in MFC 3 years ago → it's now worth $23,490.

The index would have given you $13,920.

source: institutional data · total return
What just happened
missed estimates
The last report missed estimates by 24.36%, even though full-year 2025 EPS still reached $3.00 from the quarterly figures provided.
Wall Street had the last quarter at $0.78, and Manulife delivered $0.59. That miss matters because the stock now leans on a 2026 EPS estimate of $3.25 and a raised outlook.
$0.59
reported eps
$0.78
estimated eps
24.36%
surprise
the number that mattered
The key number was the 24.36% miss, because cheap stocks stay cheap when investors stop trusting the quarterly print.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the top risk is execution on the C$5.4B reinsurance transaction. For MFC, that is not side-show news — it is a direct test of how well management can improve capital efficiency without giving away too much future earnings power.

!
high
C$5.4B reinsurance deal underdelivers
The point of the transaction is cleaner capital and lower volatility. If it weakens earnings more than it frees capital, investors will question the whole cleanup story.
risk to valuation narrative and capital efficiency
med
the stock has already rerated to the top of its range
At $35.76, MFC is basically at the top of its $21–$36 52-week range. Cheap on earnings does not guarantee upside when sentiment has already improved.
less room for disappointment at the current entry point
med
institutions have not been chasing the move
286 buyers versus 317 sellers in 3q2025 is not a panic signal, but it is a reminder that bigger money was not uniformly leaning in as the stock climbed.
ownership support looks mixed, not aggressive
~
low
returns are solid, not high enough to erase mistakes
A 14% return on equity and 12.5% return on capital are respectable. They are not so high that MFC can shrug off poor capital allocation or pricing errors.
the multiple probably stays ordinary if efficiency stalls
The combined picture is simple: you have a strong insurer with a fair valuation, but the stock now needs clean execution to justify moving beyond the top of its recent range.
source: institutional data · regulatory filings · risk analysis
Pay attention to
risk
the C$5.4B reinsurance transaction
This is the cleanest company-specific catalyst in the dataset. If it improves capital flexibility without denting earnings power, the market will care.
trend
whether the stock can hold above the old ceiling
MFC is trading near the top of its $21–$36 52-week range. Breakouts are great. Failed breakouts are educational.
metric
return on equity versus valuation
14% return on equity and 11.9x trailing earnings is the core trade-off here. If returns slip, the cheap multiple stops looking cheap.
calendar
the next quarterly update
The dataset does not give the next report date. It does give 95/100 earnings predictability, which means the next print matters less for drama and more for confirmation.
Analyst rankings
earnings predictability
95 / 100
in human-speak, analysts think this business is unusually consistent for a public stock.
risk rank
2
That puts it in the safer end of the market. You own a large insurer, not a balance-sheet dare.
price stability
90 / 100
The stock usually behaves like a grown-up. That is useful when the dividend is part of the thesis.
source: institutional data
Institutional activity

286 buyers vs. 317 sellers in 3q2025. total institutional holdings: 0.8B shares.

source: institutional data
Price targets
3-5 year target range
$30 $53
$36 current price
$42 target midpoint · +17% from current · 3-5yr high: $40 (+10% · 6% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
MFC
xvary deep dive
mfc
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it